General Information of Drug Transporter (DT)
DT ID DTD0522 Transporter Info
Gene Name CACNB4
Transporter Name Voltage-dependent L-type calcium channel beta-4
Gene ID
785
UniProt ID
O00305
Post-Translational Modification of This DT
Overview of CACNB4 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Oxidation X-Phosphorylation X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNB4 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

276

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at CACNB4 Lysine 276 has the potential to affect its expression or activity.

Oxidation

  Cystine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNB4 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

104

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at CACNB4 Cystine 104 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNB4 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

146

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at CACNB4 Cystine 146 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        17 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNB4 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 2 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNB4 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

3

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 3 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence CACNB4 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

51

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 51 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence CACNB4 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

54

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 54 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence CACNB4 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

57

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 57 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence CACNB4 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

60

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 60 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence CACNB4 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

62

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 62 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence CACNB4 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

65

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 65 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence CACNB4 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

102

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 102 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence CACNB4 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

218

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 218 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence CACNB4 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

228

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 228 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence CACNB4 [4] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

255

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 255 has the potential to affect its expression or activity.

  PTM Phenomenon 13

Have the potential to influence CACNB4 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

264

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 264 has the potential to affect its expression or activity.

  PTM Phenomenon 14

Have the potential to influence CACNB4 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

337

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 337 has the potential to affect its expression or activity.

  PTM Phenomenon 15

Have the potential to influence CACNB4 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

476

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 476 has the potential to affect its expression or activity.

  PTM Phenomenon 16

Have the potential to influence CACNB4 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

477

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 477 has the potential to affect its expression or activity.

  PTM Phenomenon 17

Have the potential to influence CACNB4 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

481

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Serine 481 has the potential to affect its expression or activity.

  Threonine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNB4 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

56

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Threonine 56 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNB4 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

99

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Threonine 99 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence CACNB4 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

207

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Threonine 207 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence CACNB4 [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

235

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Threonine 235 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence CACNB4 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

257

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Threonine 257 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence CACNB4 [4] , [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

260

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Threonine 260 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence CACNB4 [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

411

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Threonine 411 has the potential to affect its expression or activity.

  Tyrosine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence CACNB4 [4]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

55

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Tyrosine 55 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence CACNB4 [6]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

103

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Tyrosine 103 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence CACNB4 [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

232

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at CACNB4 Tyrosine 232 has the potential to affect its expression or activity.
References
1 Monoclonal antibody cocktail as an enrichment tool for acetylome analysis. Anal Chem. 2011 May 15;83(10):3623-6.
2 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
4 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
5 Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
6 Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis. J Proteome Res. 2008 Mar;7(3):1346-51.
7 An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
8 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
9 Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
10 Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal. 2011 Jun 28;4(179):rs5.
11 Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol. 2013 Nov;14(11):1166-72.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.